PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $13,000 | +30.0% | 20,800 | -7.1% | 0.00% | – |
| Q2 2016 | $10,000 | -58.3% | 22,400 | -3.0% | 0.00% | – |
| Q1 2016 | $24,000 | -67.1% | 23,100 | -6.1% | 0.00% | – |
| Q4 2015 | $73,000 | -6.4% | 24,600 | 0.0% | 0.00% | – |
| Q3 2015 | $78,000 | -75.4% | 24,600 | -54.1% | 0.00% | – |
| Q2 2015 | $317,000 | -36.0% | 53,600 | -5.4% | 0.00% | -100.0% |
| Q1 2015 | $495,000 | 0.0% | 56,648 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $495,000 | +153.8% | 56,648 | +123.0% | 0.00% | – |
| Q3 2014 | $195,000 | -14.5% | 25,400 | 0.0% | 0.00% | – |
| Q2 2014 | $228,000 | +88.4% | 25,400 | 0.0% | 0.00% | – |
| Q1 2014 | $121,000 | +98.4% | 25,400 | 0.0% | 0.00% | – |
| Q4 2013 | $61,000 | -12.9% | 25,400 | -0.8% | 0.00% | – |
| Q3 2013 | $70,000 | +9.4% | 25,600 | +44.3% | 0.00% | – |
| Q2 2013 | $64,000 | – | 17,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,134,578 | $10,654,000 | 7.22% |
| Consonance Capital Management LP | 3,427,789 | $32,187,000 | 4.15% |
| ACUTA CAPITAL PARTNERS, LLC | 604,075 | $5,672,000 | 3.83% |
| KOPP INVESTMENT ADVISORS LLC | 758,233 | $7,119,000 | 3.42% |
| Aisling Capital LLC | 2,010,000 | $18,874,000 | 2.86% |
| Broadfin Capital, LLC | 6,100,000 | $57,280,000 | 2.49% |
| THOMPSON DAVIS & CO., INC. | 154,760 | $1,453,000 | 1.68% |
| RUDMAN ERROL M | 300,000 | $2,817,000 | 1.14% |
| WALL STREET ASSOCIATES | 1,259,500 | $11,827,000 | 1.13% |
| Timpani Capital Management LLC | 291,377 | $2,736,000 | 1.08% |